<DOC>
	<DOCNO>NCT02976727</DOCNO>
	<brief_summary>Vitamin D ( Vit D ) pro-differentiation agent enhance accumulation protoporphyrin IX ( PpIX ) MAL ( methyl-aminolevulinate ) incubation actinic keratosis may significant benefit treatment actinic keratosis ablative fractional laser-primed photodynamic therapy ( AFL-PDT ) .</brief_summary>
	<brief_title>Efficacy Topical Calcipotriol-assisted AFL-PDT Actinic Keratosis</brief_title>
	<detailed_description>Photodynamic therapy ( PDT ) methyl-aminolevulinate ( MAL ) effective treatment actinic keratosis ( AK ) . Many strategy study improve production protoporphyrin IX ( PpIX ) , improve efficacy PDT . Pre-treatment skin fractional laser resurface novel alternative technique improve efficacy PDT AK . The investigator ' previous study show ablative fractional laser prim PDT ( AFL-PDT ) offer high efficacy conventional MAL-PDT treatment AK . But , reduce response rate also observe thicker skin lesion , may due insufficient PpIX accumulation within target tissue . Cellular differentiation lead increase synthesis PpIX MAL consecutively , differentiation therapy enhance photosensitization effect . Topical calcipotriol well-known pro-differentiation hormone demonstrate influence effect PDT keratinocytes . The aim study evaluate efficacy topical vitamin D AFL-PDT AK treatment . Consequently , investigator compare efficacy , recurrence rate , cosmetic outcome safety VitD - AFL-PDT conventional AFL-PDT .</detailed_description>
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<mesh_term>Skin Diseases</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Calcitriol</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Prilocaine</mesh_term>
	<mesh_term>EMLA</mesh_term>
	<mesh_term>Calcipotriene</mesh_term>
	<criteria>Korean patient age â‰¥ 18 year biopsyconfirmed Actinic keratosis lesion calcium metabolic disorder patient photosensitivity disorder patient lactate pregnant woman patient porphyria know allergy constituent MAL cream lidocaine patient systemic disease , history malignant melanoma , tendency melasma development keloid formation , AK treatment area previous 4 week , condition associate risk poor protocol compliance ; patient immunosuppressive treatment</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Vitamin D</keyword>
	<keyword>Calcipotriol</keyword>
	<keyword>Ablative fractional laser</keyword>
	<keyword>Actinic keratosis</keyword>
	<keyword>Photodynamic therapy</keyword>
</DOC>